Revolution Medicines, Inc. is 4.2x more valuable than ImmunityBio, Inc. by market capitalization ($30.65 B vs $7.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IBRX | RVMD |
|---|---|---|
| Market cap | $7.31 B | $30.65 B |
| US-listed rank | #1120 | #454 |
| Revenue (latest FY) | $113.29M | $0.00 |
| Net income (latest FY) | -$351.50M | -$1.13B |
| Net margin | -310.3% | - |
| SEC filings | 528 | 782 |
Revolution Medicines, Inc. is 4.2x more valuable than ImmunityBio, Inc. by market capitalization ($30.65 B vs $7.31 B).
In their latest fiscal years, ImmunityBio, Inc. reported $113.29M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: ImmunityBio, Inc. and Revolution Medicines, Inc., or browse the full rankings.